Equibles does not estimate personal net worth.
Adam Levy is recorded as CFO at Mineralys Therapeutics, Inc. (MLYS). The proxy statement of Mineralys Therapeutics, Inc. reports total compensation of $2,203,096 for Adam Levy in fiscal 2025, including a base salary of $532,000. Disclosed compensation is on record for 4 fiscal years. Adam Levy has spoken on 11 earnings calls and 3 other investor events across 1 company, most recently for Mineralys Therapeutics, Inc. on September 9, 2026. Mineralys Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Mineralys Therapeutics, Inc. includes Jon Congleton (CEO and Board Member), Glenn P. Sblendorio (Chairman), Alexander Gold (Board Member) and 7 others.
“So we've been interested in partnering and we've publicly discussed our desires to partner if there's the right opportunity to maximize the value for their understat that could look like a partner that helps commercialize more broadly around the world, potentially help develop their understat.”
“Today, I will discuss select portions of our second quarter of 2026 financial results. Additional details can be found in our Form 10-Q, which will be filed with the SEC today.”
“So we had the opportunity to buy back the royalties from Tanabe for $200 million up front, and $100 million in future potential commercial milestones. The future milestones are based on certain thresholds, and we believe that they will be totally paid for by the savings and the royalty.”
“Today, I will discuss select portions of our first quarter 2026 financial results. Additional details can be found in our Form 10-Q, which will be filed with the SEC today.”
Biotechnology · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Mineralys Therapeutics, Inc. (MLYS) | Chief Financial Officer and Secretary | $532,000 | $2,203,096 |
| 2024 | Mineralys Therapeutics, Inc. (MLYS) | Chief Financial Officer and Secretary | $500,000 | $2,849,200 |
| 2023 | Mineralys Therapeutics, Inc. (MLYS) | Chief Financial Officer and Secretary | $450,000 | $2,176,181 |
| 2022 | Mineralys Therapeutics, Inc. (MLYS) | Chief Financial Officer and Secretary | $334,926 | $1,016,588 |
